Altasciences
↗Laval, Quebec, Canada
Altasciences is a leading, fully-integrated contract research organization (CRO) and contract development and manufacturing organization (CDMO) headquartered in Laval, Canada. Founded in 1992, the company provides comprehensive early-phase drug development solutions to pharmaceutical and biotech companies of all sizes. The company operates an integrated platform spanning preclinical safety testing, clinical pharmacology, proof-of-concept studies, bioanalysis, formulation, manufacturing, and analytical services across 8-9 facilities in North America. With over 1,800 employees and a 30-year history, Altasciences conducts over 700 safety studies annually and has facilitated more than 2,850 clinical trials from its Montreal facility alone. The company is recognized for its fully integrated end-to-end CRO/CDMO solution, allowing clients to treat drug development as a seamless continuum rather than discrete steps, enabling faster timelines and more efficient development.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Contract Research Organization (CRO) / Contract Development and Manufacturing Organization (CDMO)
Sub-Industry:Early-phase drug development, preclinical safety testing, clinical pharmacology, pharmaceutical manufacturing
SIZE & FINANCIALS
Employees:1001-5000
Founded:1992
Ownership:private
Status:operating
FUNDING
Investors:Novo Holdings A/S, Audax Private Equity, Kilmer Capital Partners
PIPELINE
Stage:Preclinical to Phase II (early-phase development)
Lead Drug Stage:Not applicable (CRO/CDMO - supports client compounds)
Modalities:Small molecule, Large molecules, Biologics, Monoclonal antibodies
Trial Phases:-
CORPORATE STRUCTURE
Parent Company:Novo Holdings A/S
Acquired By:Novo Holdings A/S (2021-03-29)
Key Partnerships:VoxCell BioInnovation (2025 collaboration for 3D bioprinted tissue platforms in preclinical testing)
COMPETITION
Position:Leader
Competitors:Celerion, Ask Gene Pharma, AWAKN, Allucent, Atlant Clinical, BioAgilytix Labs, Theorem Clinical Research, Ergomed +2 more
LEADERSHIP
Key Executives:
Chris Perkin - Chief Executive Officer
Marie-Hélène Raigneau - President
Mariano Rodriguez - Chief Financial Officer, Executive Vice President
Scientific Founders:Team of researchers from the pharmacology department of Université de Montréal (1992)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Altasciences. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.